Acute biphenotypic leukemia
Acute Biphenotypic Leukemia
Acute Biphenotypic Leukemia (pronunciation: a-kyoot by-fen-o-typ-ik loo-kee-mee-uh), also known as Mixed Phenotype Acute Leukemia (MPAL), is a rare type of leukemia that does not fit well into the standard classification of leukemia. The term "biphenotypic" refers to the presence of two different types of cells, myeloid and lymphoid, in the same individual.
Etymology
The term "Acute Biphenotypic Leukemia" is derived from the Greek words "akutos" (meaning sharp or severe), "bi" (meaning two), "phenos" (meaning show or appear) and "leukos" (meaning white) and "haima" (meaning blood).
Diagnosis
Diagnosis of Acute Biphenotypic Leukemia is based on the identification of both myeloid and lymphoid cells in the blood or bone marrow. This is typically done through a bone marrow biopsy and cytogenetic analysis.
Treatment
Treatment for Acute Biphenotypic Leukemia typically involves chemotherapy, and may also include stem cell transplantation.
Prognosis
The prognosis for Acute Biphenotypic Leukemia varies depending on a number of factors, including the patient's age, overall health, and the specific characteristics of the leukemia cells.
Related Terms
- Leukemia
- Myeloid
- Lymphoid
- Bone marrow biopsy
- Cytogenetic analysis
- Chemotherapy
- Stem cell transplantation
External links
- Medical encyclopedia article on Acute biphenotypic leukemia
- Wikipedia's article - Acute biphenotypic leukemia
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski